PTPN14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.345200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.376800E-01
Normal-vs-Stage2
3.680400E-01
Normal-vs-Stage3
8.900400E-01
Normal-vs-Stage4
1.113630E-01
Stage1-vs-Stage2
8.360300E-02
Stage1-vs-Stage3
4.046200E-01
Stage1-vs-Stage4
3.539800E-02
Stage2-vs-Stage3
2.481400E-01
Stage2-vs-Stage4
1.695210E-01
Stage3-vs-Stage4
4.458500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.436000E-01
Normal-vs-AfricanAmerican
2.581400E-01
Normal-vs-Asian
6.268200E-01
Caucasian-vs-AfricanAmerican
6.604800E-01
Caucasian-vs-Asian
4.595600E-01
AfricanAmerican-vs-Asian
2.674200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.465400E-01
Normal-vs-Female
4.127400E-01
Male-vs-Female
5.279400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.329200E-01
Normal-vs-Age(41-60Yrs)
2.311400E-01
Normal-vs-Age(61-80Yrs)
5.270800E-01
Normal-vs-Age(81-100Yrs)
6.570600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.017600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.850200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.792800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.323590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.097230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.765400E-01
Normal-vs-Daily Drinker
7.258600E-01
Normal-vs-Weekly Drinker
4.373800E-01
Normal-vs-Occasional Drinker
3.706800E-01
Normal-vs-Social Drinker
4.249000E-01
Non Drinker-vs-Daily Drinker
5.277800E-01
Non Drinker-vs-Weekly Drinker
7.753200E-01
Non Drinker-vs-Occasional Drinker
2.048400E-01
Non Drinker-vs-Social Drinker
2.527400E-01
Daily Drinker-vs-Weekly Drinker
4.556000E-01
Daily Drinker-vs-Occasional Drinker
1.203210E-01
Daily Drinker-vs-Social Drinker
1.711550E-01
Weekly Drinker-vs-Occasional Drinker
3.125000E-01
Weekly Drinker-vs-Social Drinker
3.306000E-01
Occasional Drinker-vs-Social Drinker
8.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.365200E-01
Normal-vs-Grade 2
3.069900E-02
Normal-vs-Grade 3
1.144380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.838900E-03
Grade 1-vs-Grade 3
7.571600E-04
Grade 1-vs-Grade 4
2.365200E-01
Grade 2-vs-Grade 3
6.796300E-02
Grade 2-vs-Grade 4
3.069900E-02
Grade 3-vs-Grade 4
1.144380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.592800E-01
Normal-vs-NonDiabetic
4.525000E-01
Diabetic-vs-NonDiabetic
8.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.282630E-01
Normal-vs-NoPancreatitis
5.118600E-01
Pancreatitis-vs-NoPancreatitis
4.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.809800E-01
Normal-vs-N1
3.201400E-01
N0-vs-N1
8.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.943030E-01
Normal-vs-TP53-NonMutant
5.760200E-01
TP53-Mutant-vs-TP53-NonMutant
1.622070E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
